Compare HIND & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HIND | PRZO |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | Israel |
| Employees | 2 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 17.5M |
| IPO Year | 2016 | 2022 |
| Metric | HIND | PRZO |
|---|---|---|
| Price | $2.00 | $0.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 4.7K | ★ 2.8M |
| Earning Date | 05-20-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $319,714.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.43 | N/A |
| 52 Week Low | $1.75 | $0.38 |
| 52 Week High | $6.56 | $1.90 |
| Indicator | HIND | PRZO |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 46.96 |
| Support Level | $1.99 | $0.66 |
| Resistance Level | $2.32 | $0.82 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 14.07 | 19.06 |
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.